Merck KGaA - Company Profile
Powered by
All the data and insights you need on Merck KGaA in one report.
- Save hours of research time and resources with
our up-to-date Merck KGaA Strategy Report
- Understand Merck KGaA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreMerck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops, and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility; and develops liquid crystal mixtures, organic light-emitting diode (OLED) materials, cosmetic active ingredients, pigments for coatings, and high-tech materials. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments and end-to-end systems. The company serves healthcare, performance materials, and life sciences markets. It has a presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.
Merck KGaA premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Prescription Drugs: | - | - |
Oncology | Single-use Manufacturing | Apaisyl |
Neurology & Immunology | Sterile Filtration | Bion |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | New Products/Services | In April, the company launched the Aptegra CHO genetic stability assay, the first all-in-one, validated genetic stability assay. |
2024 | Corporate Changes/Expansions | In March, the company opened a new office in Riyadh, Saudi Arabia. |
2024 | Corporate Changes/Expansions | In March, the company expanded its M LabTM Collaboration Center in Shanghai. |
Competitor Comparison
Key Parameters | Merck KGaA | F. Hoffmann-La Roche Ltd | Bayer AG | Sanofi | Novartis AG |
---|---|---|---|---|---|
Headquarters | Germany | Switzerland | Germany | France | Switzerland |
City | Darmstadt | Basel | Leverkusen | Paris | Basel |
State/Province | Hessen | - | Nordrhein-Westfalen | Ile-de-France | - |
No. of Employees | 62,908 | 103,605 | 99,723 | 87,994 | 76,057 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Belen Garijo | Chief Executive Officer | Senior Management | 2021 | 64 |
Helene von Roeder | Chief Financial Officer | Senior Management | 2023 | 54 |
Peter Guenter | Chief Executive Officer - Healthcare | Senior Management | 2021 | 62 |
Matthias Heinzel | Chief Executive Officer - Life Science | Senior Management | 2021 | 56 |
Kai Beckmann | Chief Executive Officer - Electronics business | Senior Management | 2017 | 59 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward